(AHAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AHAC | FATE | ANTX | ||
| Company | Symbol not found | Fate Therapeutics | An2 Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.20 | 1.2300 | 4.88 | ||
| High | 11.27 | 1.2600 | 6.00 | ||
| Low | 10.17 | 1.1650 | 4.71 | ||
| Latest | 10.96 | 1.1700 | 5.44 | ||
| Change | +0.81 | -0.0600 | +0.35 | ||
| % Change | +7.98% | -4.88% | +6.88% | ||
| Volume | 298,100 | 1,054,000 | 1,442,500 | ||
| 20-Day Average Volume | 225,550 | 1,680,530 | 3,765,305 | ||
| Previous Close | 10.15 | 1.2300 | 5.09 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 10.03 | 1.3860 | 2.05 | ||
| 20-Day Raw Stochastic | 85.58% | 4.55% | 75.13% | ||
| 20-Day Relative Strength | 65.19 | 44.63 | 88.33 | ||
| Weighted Alpha | +5.70 | -13.24 | +32.32 | ||
| Today's Opinion | N/A | 32% Buy | 100% Buy | ||
| Previous Opinion | N/A | 88% Buy | 100% Buy | ||
| Last Month's Opinion | N/A | 48% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +19.00% since 08/19/21 | -15.22% since 03/05/26 | +218.13% since 03/05/26 | ||
| Low | 9.26 on 08/20/21 | 1.1650 on 03/12/26 | 1.57 on 03/06/26 | ||
| High | 11.27 on 08/26/21 | 1.3800 on 03/10/26 | 6.91 on 03/09/26 | ||
| 1-Month | |||||
| %Chg | +9.38% since 07/26/21 | -2.50% since 02/12/26 | +418.10% since 02/12/26 | ||
| Low | 9.12 on 08/19/21 | 1.1650 on 03/12/26 | 1.00 on 02/19/26 | ||
| High | 11.27 on 08/26/21 | 1.6950 on 02/25/26 | 6.91 on 03/09/26 | ||
| 3-Month | |||||
| %Chg | +10.48% since 05/26/21 | +1.74% since 12/12/25 | +353.33% since 12/12/25 | ||
| Low | 9.12 on 08/19/21 | 0.9510 on 12/23/25 | 1.00 on 02/19/26 | ||
| High | 11.27 on 08/26/21 | 1.6950 on 02/25/26 | 6.91 on 03/09/26 | ||
| 6-Month | |||||
| %Chg | -5.52% since 02/26/21 | +21.48% since 09/12/25 | +325.00% since 09/12/25 | ||
| Low | 9.12 on 08/19/21 | 0.9401 on 09/15/25 | 1.00 on 02/19/26 | ||
| High | 12.40 on 03/22/21 | 1.9399 on 10/27/25 | 6.91 on 03/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 140,891 | 143,004 | 139,476 | ||
| Shares Outstanding, K | 12,855 | 116,263 | 27,402 | ||
| Annual Sales | 0 | 6,650,000 | 0 | ||
| Annual Net Income | -230,000 | -136,320,000 | -51,320,000 | ||
| Last Quarter Sales | 0 | 1,370,000 | 0 | ||
| Last Quarter Net Income | 290,000 | -32,370,000 | -9,350,000 | ||
| 60-Month Beta | N/A | 2.19 | -0.02 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.27 on 11/13/25 | -0.31 on 11/12/25 | ||
| Latest Earnings Date | 01/01/70 | 05/12/26 | 03/24/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||